Inactive Instrument

All News RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C3034

End-of-day quote Nasdaq Other stock markets
- ^USD	-

15/05	Phio Pharmaceuticals Doses 1st Group in Skin Cancer Treatment Study	MT
15/05	Phio Pharmaceuticals Corp Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)	16/05	AQ
Phio Pharmaceuticals Doses 1st Group in Skin Cancer Treatment Study	15/05	MT
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study	15/05	AQ
Phio Pharmaceuticals Corp Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study	15/05	CI
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update	10/05	GL
Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)	30/04	AQ
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells	22/04	AQ
Phio Pharmaceuticals Corp. Presents New Data About Its Lead Clinical Product Candidate, PH-762	22/04	CI
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)	16/04	AQ
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology	16/04	CI
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)	11/04	AQ
National Spotlight Features Phio’s Innovative RNAi Technology Platform	03/04	AQ
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update	02/04	GL
North American Morning Briefing : Stocks Seen -2-	02/04	DJ
Phio Pharmaceuticals Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies	21/03	AQ
Phio Pharmaceuticals Corp. Presents Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies	21/03	CI
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research	13/03	AQ
Phio Pharmaceuticals Corp. Announces Addition of Clinical Trial Sites At Banner Md Anderson Cancer Center, the George Washington University, and Integrity Research	13/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C3034

All News

Filters